Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Merkel Cell × Everolimus × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 16 Carcinoma, Renal Cell 10 Neuroendocrine Tumors 8 Neoplasm Metastasis 8 Recurrence 5 Endometrial Neoplasms 4 Tuberous Sclerosis 3 Neoplasms 3 Glioma 3 Glioblastoma 3 von Hippel-Lindau Disease 2 Triple Negative Breast Neoplasms 2 Skin Neoplasms 2 Sarcoma 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Meningioma 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Kidney Neoplasms 2 Gastro-enteropancreatic neuroendocrine tumor 2 Diffuse Intrinsic Pontine Glioma 2 Carcinoma, Hepatocellular 2 Brain Neoplasms 2 Adenoma, Islet Cell 2 Waldenstrom Macroglobulinemia 1 Vascular Malformations 1 Thyroid cancer, Hurthle cell 1 Thyroid Neoplasms 1 Thyroid Diseases 1 Thymus Neoplasms 1 Seizures 1

Interventions

pembrolizumab 16 Nivolumab 12 avelumab 8 Ipilimumab 6 Specimen Handling 5 Biopsy 5 atezolizumab 4 Magnetic Resonance Spectroscopy 4 cemiplimab 3 Cyclophosphamide 3 poly ICLC 2 fludarabine phosphate 2 fludarabine 2 aldesleukin 2 Radiotherapy 2 Radiosurgery 2 Interleukin-2 2 Immunoglobulin G 2 Docetaxel 2 Bevacizumab 2 tocilizumab 1 talimogene laherparepvec 1 sargramostim 1 relatlimab 1 regorafenib 1 prednylidene 1 lutetium Lu 177 dotatate 1 lenvatinib 1 flt3 ligand protein 1 efineptakin alfa 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡